Wai Chun Bio-Technology Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Wai Chun Bio-Technology Limited
Access all reports
Wai Chun Bio-Technology Limited is a Hong Kong-based investment holding company engaged in the trading and distribution of modified starch and other biochemical products. The company’s operations include sourcing, processing, and selling agricultural and industrial-grade starch products used in food processing, paper manufacturing, textiles, and other industrial applications. Wai Chun Bio-Technology also explores opportunities in related sectors to diversify its business portfolio. The company is headquartered in Hong Kong, and its shares are listed on the HKEX.
Latest articles
)
Upcoming IPOs to Watch in 2025
Potential IPOs in 2025 include prominent names like Shein, Databricks, Klarna, eToro, and Figma, to name a few. Let's take a closer look.
23 May 2025
)
Figma: Collaborative Design Tool Ready for IPO
Figma, the popular design platform, is preparing for a potential IPO in 2025 as it continues to reshape the future of collaborative design.
22 May 2025
)
Companies That Had Their IPO in 2024: Momentum Increasing
2024 marked a steady year for IPOs, driven by strong markets, AI momentum, and high-profile listings across industries and regions.
22 May 2025
Ticker symbol
660
Country
🇭🇰 Hong Kong